» Articles » PMID: 9413984

Solution Structure of the KIX Domain of CBP Bound to the Transactivation Domain of CREB: a Model for Activator:coactivator Interactions

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 1997 Dec 31
PMID 9413984
Citations 302
Authors
Affiliations
Soon will be listed here.
Abstract

The nuclear factor CREB activates transcription of target genes in part through direct interactions with the KIX domain of the coactivator CBP in a phosphorylation-dependent manner. The solution structure of the complex formed by the phosphorylated kinase-inducible domain (pKID) of CREB with KIX reveals that pKID undergoes a coil-->helix folding transition upon binding to KIX, forming two alpha helices. The amphipathic helix alphaB of pKID interacts with a hydrophobic groove defined by helices alpha1 and alpha3 of KIX. The other pKID helix, alphaA, contacts a different face of the alpha3 helix. The phosphate group of the critical phosphoserine residue of pKID forms a hydrogen bond to the side chain of Tyr-658 of KIX. The structure provides a model for interactions between other transactivation domains and their targets.

Citing Articles

The transcription factor CREB regulates epithelial-mesenchymal transition of lens epithelial cells by phosphorylation-dependent and phosphorylation-independent mechanisms.

Zhang L, Wang J, Wang L, Zheng S, Bai Y, Fu J J Biol Chem. 2024; 301(1):108064.

PMID: 39662835 PMC: 11773003. DOI: 10.1016/j.jbc.2024.108064.


Multi-faceted regulation of CREB family transcription factors.

Chowdhury M, Haq M, Lee J, Jeong S Front Mol Neurosci. 2024; 17:1408949.

PMID: 39165717 PMC: 11333461. DOI: 10.3389/fnmol.2024.1408949.


Bipartite binding interface recruiting HP1 to chromosomal passenger complex at inner centromeres.

Sako K, Furukawa A, Nozawa R, Kurita J, Nishimura Y, Hirota T J Cell Biol. 2024; 223(9).

PMID: 38781028 PMC: 11116813. DOI: 10.1083/jcb.202312021.


Experimental methods to study the structure and dynamics of intrinsically disordered regions in proteins.

Maiti S, Singh A, Maji T, Saibo N, De S Curr Res Struct Biol. 2024; 7:100138.

PMID: 38707546 PMC: 11068507. DOI: 10.1016/j.crstbi.2024.100138.


p300/CBP degradation is required to disable the active AR enhanceosome in prostate cancer.

Luo J, Chen Z, Qiao Y, Tien J, Young E, Mannan R bioRxiv. 2024; .

PMID: 38586029 PMC: 10996709. DOI: 10.1101/2024.03.29.587346.